NCT06166667Completed
Effect of Fecal Capsule on Chronic Kidney Disease (CKD)
Source: ClinicalTrials.gov · Last updated 16 May 2025
Brief summary (registry, in English)
By collecting blood, urine and stool samples before and after oral Enterobacteriaceae capsule (FMT) from CKD subjects, we investigated the role and related mechanisms of gut microecology in the development of CKD using a combination of metagenomic sequencing, metabolomic analysis and flow cytometry.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 20 (actual)
- First submitted
- 6 May 2023
- Start date
- 1 Mar 2023
- Primary completion date
- 31 Dec 2023
- Lead sponsor
- Shanxi Provincial People's Hospital
- Diseases
- Chronic kidney disease
- NCT number
- NCT06166667
What you commit to
- Study type: Interventional
- Participants enrolled: 20
- From 1 Mar 2023 to the primary completion date, 31 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Active systemic infections or severe infections within 1 month prior to enrollment, including HIV, HBV, HCV
Other illness
- Presence of malignancy and other diseases with expected survival time \< 3 months
- Presence of active gastrointestinal bleeding or acute and chronic gastrointestinal inflammation
- Psychosis and cognitive impairment
- History of alcohol or drug abuse
Lab values
- White blood cell count \< 3.0x109/l; Platelet count \< 80x109 / L, or had other hematologic diseases
Other
- Had taken antibiotics for nearly 14 days
- Presence of IBD, CDI, or gastrointestinal tumors
- Were or had undergone FMT
- Pregnant or lactating women
- Difficult to follow-up
- Difficult or unwilling to cooperate
Who the study is looking for
- Subjects: Patients with chronic kidney disease (CKD)
- GFR ≥ 30 ml / min, or serum creatinine ≤ 442 μ mol/L
- Negative urine pregnancy test and no plans for pregnancy for the next 18 months, enabling effective contraception
- Age: 18-70 years
- Signed informed consent for clinical studies informed consent for treatment of patients with flora transplantation (FMT)
Age in the registry: 18 years to 70 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Shanxi Provincial People's Hospita Coordinator of this site? Confirm its status | Taiyuan | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.